"The University of Florida Center for Movement Disorders & Neurorestoration is founded on the philosophy that integrated, interdisciplinary care is the most effective approach for patients with movement disorders."

During the past decade, University of Florida Center for Movement Disorders and Neurorestoration conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 8 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Florida Center for Movement Disorders and Neurorestoration" #1 sponsor was "University of Florida" with 18 trials, followed by "Pfizer" with 3 trials sponsored, "Revance Therapeutics, Inc." with 3 trials sponsored, "Ipsen" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florida Center for Movement Disorders and Neurorestoration" #1 collaborator was "Medtronic" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Brain and Spinal Cord Injury Research Trust Fund" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "University of Florida Center for Movement Disorders and Neurorestoration" are "Cervical Dystonia" (5 trials), "Parkinson's Disease" (5 trials), "Dystonia" (4 trials), "Parkinson Disease" (4 trials) and "Parkinsons Disease" (3 trials). Many other conditions were trialed in "University of Florida Center for Movement Disorders and Neurorestoration" in a lesser frequency.

Most popular intervention types in "University of Florida Center for Movement Disorders and Neurorestoration" are "Drug" (14 trials), "Other" (12 trials), "Device" (10 trials), "Biological" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Biphasic DBS stimulation" (2 trials), "Botulinum toxin type A" (2 trials), "Capsaicin" (2 trials) and "Demographic Data" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Florida Center for Movement Disorders and Neurorestoration" are 33 trials for "All" genders.

Currently, there are NaN active trials in "University of Florida Center for Movement Disorders and Neurorestoration". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in University of Florida Center for Movement Disorders and Neurorestoration, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Florida Center for Movement Disorders and Neurorestoration, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".